Xanthohumol, a prenylated chalcone from Humulus lupulus L.; Inhibits cholesteryl ester transfer protein

Food Chemistry

Volumn 134, Issue 3, 2012, Pages 1432-1437

  Hirata, Hiroshi ^a   Takazumi, Koji ^a   Segawa, Shuichi ^a   Okada, Yukio ^a   Kobayashi, Naoyuki ^a   Shigyo, Tatsuro ^a   Chiba, Hitoshi ^b  

^a SAPPORO BREWERIES LTD   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Chalcone; Cholesteryl ester transfer protein; Hop; Prenyl group; Xanthohumol

Indexed keywords

CHALCONES; CHOLESTERYL ESTER TRANSFER PROTEINS; HOP; PRENYL GROUP; XANTHOHUMOL;

CHOLESTEROL; ESTERS; PROTEINS;

ESTERIFICATION;

4',6' DIMETHOXY 2 2' HYDROXY 2 PHENYLACETOPHENONE; 5 METHOXYRESORCINOL; ADLUPULONE; CARDAMONIN; CHALCONE DERIVATIVE; CHOLESTEROL ESTER TRANSFER PROTEIN; COLUPULON; DESMETHYLXANTHOHUMOL; HUMULON; ISOLIQUIRITIGENIN; ISOXANTHOHUMOL; LUPULON; NARINGENIN; PARA COUMARIC ACID; PHLORETIN; PLANT MEDICINAL PRODUCT; QUERCETIN; UNCLASSIFIED DRUG; XANTHOHUMOL; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROPIOPHENONE DERIVATIVE;

ARTICLE; DRUG STRUCTURE; HUMULUS LUPULUS; INHIBITION KINETICS; CHEMISTRY; HUMULUS;

HUMULUS LUPULUS;

CHALCONES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FLAVONOIDS; HUMULUS; PROPIOPHENONES;

EID: 84861100733     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2012.03.043     Document Type: Article

References (28)

1. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Cholesterol treatment trialists' (CTT) collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. P. Barter, A.M. Gotto, J.C. LaRosa, J. Maroni, M. Szarek, and S.M. Grundy HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events New England Journal of Medicine 357 2007 1301 1310
3. E. Braunwald Shattuck lecture-cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities New England Journal of Medicine 337 1997 1360 1369
4. M.L. Brown, A. Inazu, C.B. Hesler, L.B. Agellon, C. Mann, and M.E. Whitlock Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins Nature 342 1989 448 451
5. H. Chiba, H. Akita, K. Tsuchihashi, S.P. Hui, Y. Takahashi, and H. Fuda Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency Journal of Lipid Research 38 1997 1204 1216
6. R.W. Clark, R.B. Ruggeri, D. Cunningham, and M.J. Bamberger Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action Journal of Lipid Research 47 2006 537 552
7. D. Cunningham, W. Lin, L.R. Hoth, D.E. Danley, R.B. Ruggeri, and K.F. Geoghegan Biophysical and biochemical approach to locating an inhibitor binding site on cholesteryl ester transfer protein Bioconjugate Chemistry 19 2008 1604 1613
8. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham study American Journal of Medicine 62 1977 707 714
9. L.S. Harikrishnan, M.G. Kamau, T.F. Herpin, G.C. Morton, Y. Liu, and C.B. Cooper Michael Lawrence R. 2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: Optimization via array synthesis Bioorganic & Medicinal Chemistry Letters 18 2008 2640 2644
10. I. Jantan, M.M. Pisar, M.S. Idris, M. Taher, and R.M. Ali In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding Planta Medica 68 2002 1133 1134
11. A. Keech, R.J. Simes, P. Barter, J. Best, R. Scott, and M.R. Taskinen FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial Lancet 366 2005 1849 1861
12. C.K. Lam, Z. Zhang, H. Yu, S.Y. Tsang, Y. Huang, and Z.Y. Chen Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol Molecular Nutrition & Food Research 52 2008 950 958
13. S.W. Leonard, J.D. Joss, D.J. Mustacich, D.H. Blatt, Y.S. Lee, and M.G. Traber Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins American Journal of Health System Pharmacy 64 2007 2257 2266
14. P. Libby, and M. Aikawa Stabilization of atherosclerotic plaques: New mechanisms and clinical targets Nature Medicine 8 2002 1257 1262
15. R.W. Mahley, Y. Huang, and K.H. Weisgraber Putting cholesterol in its place. apoE and reverse cholesterol transport Journal of Clinical Investigation 116 2006 1226 1229
16. K.R. Marotti, C.K. Castle, T.P. Boyle, A.H. Lin, R.W. Murray, and G.W. Melchior Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein Nature 364 1993 73 75
17. F. Matsuura, N. Wang, W. Chen, X.C. Jiang, and A.R. Tall HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway Journal of Clinical Investigation 116 2006 1435 1442
18. J. Nagel, L.K. Culley, Y. Lu, E. Liu, P.D. Matthews, and J.F. Stevens EST analysis of hop glandular trichomes identifies an O-methyltransferase that catalyzes the biosynthesis of xanthohumol Plant Cell 20 2008 186 200 [pubMed: 18223037]
19. A. Nookandeh, N. Frank, F. Steiner, R. Ellinger, B. Schneider, and C. Gerhäuser Xanthohumol metabolites in faeces of rats Phytochemistry 65 2004 561 570
20. H. Okamoto, F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits Nature 406 2000 203 207
21. X. Qiu, A. Mistry, M.J. Ammirati, B.A. Chrunyk, R.W. Clark, and Y. Cong Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules Nature Structural & Molecular Biology 14 2007 106 113
22. E. Quinet, A. Tall, R. Ramakrishnan, and L. Rudel Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins Journal of Clinical Investigation 87 1991 1559 1566
23. M. Ranalletta, K.K. Bierilo, Y. Chen, D. Milot, Q. Chen, and E. Tung Biochemical characterization of cholesteryl ester transfer protein inhibitors Journal of Lipid Research 51 2010 2739 2752
24. A.L. Romero, K.L. West, T. Zern, and M.L. Fernandez The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs Journal of Nutrition 132 2002 1194 1198
25. E.C. Row, S.A. Brown, A.V. Stachulski, and M.S. Lennard Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4 Bioorganic & Medicinal Chemistry 14 2006 3865 3871
26. N. Satoh, A. Shimatsu, K. Kotani, N. Sakane, K. Yamada, and T. Suganami Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome Diabetes Care 30 2007 144 146
27. S. Shrestha, H.C. Freake, M.M. McGrane, J.S. Volek, and M.L. Fernandez A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake Journal of Nutrition 137 2007 1165 1170
28. T.L. Zern, and M.L. Fernandez Cardioprotective effects of dietary polyphenols Journal of Nutrition 135 2005 2291 2294